June 26, 2008 |
THURSDAY, June 26 (HealthDay News) -- Women with metastatic breast cancer who developed an immune response to an investigational vaccine lived twice as long as those who didn't have an immune response, new research shows. "If you were an immune responder, you had double the survival of a non-responder," said study author Dr. Susan Domchek, an associate professor of medicine at the University of Pennsylvania. Her report is one of several focusing on breast cancer vaccines expected to be discussed this week at the Department of Defense...
February 9, 2012 |
In the early '90s, a Simi Valley, Calif., woman named Charlotte Haley, appalled at the minuscule amount of money going to cancer research, created the first breast cancer ribbon. It was an orangey-pink — salmon-colored, really — and made of fabric. Haley, who was not only a breast cancer survivor but also had seen numerous friends and family members suffer from the disease, began attaching her ribbon to cards she sent out with the words "Breast Cancer Awareness Ribbon. . . . Join this grassroots...
October 31, 2011
Cancer Treatment Odds of breast cancer recurrence decline when radiation follows surgery THE QUESTION Does having radiation treatment after breast cancer surgery make a difference in whether the cancer returns? THIS STUDY combined and analyzed data from 17 studies, involving 10,801 women who had surgery for breast cancer in which part but not all of their breast was removed and who had been randomly assigned to have radiation treatment or no radiation after the surgery.
July 8, 2008
TUESDAY, July 8 (HealthDay News) -- The U.S. Food and Drug Administration has approved a genetic test designed to evaluate whether a person with breast cancer is a good candidate for treatment with the drug Herceptin (trastuzumab). The SPOT-Light HER2 CISH test measures how many copies of the HER2 gene are in breast tumor cells. People with breast cancer may have more than the normal two copies of this gene in each breast cell, which can cause overactive cell growth and division.
February 14, 2008
THURSDAY, Feb. 14 (HealthDay News) -- A new Canadian study may finally explain how a key compound found in the U.S.-banned insecticide DDT accelerates the growth of breast cancer tumors. The new report, published in the open access journalBreast Cancer Research, suggests that DDT's main metabolite blocks a pathway of a hormone that would otherwise help inhibit growth in normally responsive breast cancer cells. In their study, researchers from Universite Laval and Institut national de sant publique in Quebec found that the...
July 7, 2008
MONDAY, July 7 (HealthDay News) -- A compound found in red grapes and red wine suppresses abnormal cell formation that leads to most types of breast cancer, according to U.S. researchers. The compound, resveratrol, is sold in extract form as a dietary supplement. Breast cancer forms through a multi-stage process that differs depending on the type of disease, a person's genes, and other factors. However, it's known that increased estrogen fuels many types of breast cancer. "Resveratrol has the ability to prevent the first step...